Author:
Feagan Brian G.,Sandborn William J.,D'Haens Geert,Pola Suresh,McDonald John W.D.,Rutgeerts Paul,Munkholm Pia,Mittmann Ulrich,King Debra,Wong Cindy J.,Zou Guangyong,Donner Allan,Shackelton Lisa M.,Gilgen Denise,Nelson Sigrid,Vandervoort Margaret K.,Fahmy Marianne,Loftus Edward V.,Panaccione Remo,Travis Simon P.,Van Assche Gert A.,Vermeire Séverine,Levesque Barrett G.
Funder
Millennium Pharmaceuticals, Merck, Tillotts Pharma AG, Abbott Laboratories, Novartis Pharmaceuticals, Centocor, Elan/Biogen, UCB Pharma, Bristol-Myers Squibb, Genentech, ActoGeniX, and Wyeth
Abbott Laboratories, Bristol-Myers Squibb, Genentech, GlaxoSmithKline, Janssen, Millennium Pharmaceuticals, Novartis, Pfizer, Procter and Gamble, Shire, and UCB Pharma
Merck, Abbott Laboratories, Centocor, Given Imaging, UCB Pharma, and ActoGeniX
Centocor, Merck, UCB, and Abbott Laboratories
Abbott Laboratories, UCB Pharma, Janssen Biotech, Amgen, GlaxoSmithKline, Millennium-Takeda, Braintree Labs, Bristol-Myers Squibb, Pfizer, Genentech, Santarus, and Shire
Ferring, Abbott Laboratories, Schering-Plough, Merck Sharpe & Dohme, Procter & Gamble, Warner Chilcott, and the International Organization of IBD
Merck, Abbott, and Janssen
Abbott Laboratories, MSD, and UCB
Tillotts Pharma AG
Subject
Gastroenterology,Hepatology
Reference38 articles.
1. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee;Kornbluth;Am J Gastroenterol,2010
2. Guidelines for the management of inflammatory bowel disease in adults;Mowat;Gut,2011
3. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management;Dignass;J Crohns Colitis,2012
4. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis;Feagan;Cochrane Database Syst Rev,2012
5. Efficacy of delayed-release oral mesalamine in patients who received previous ulcerative colitis treatment;Hanauer;Gastroenterology,2008